New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
19:03 EDTTKMR, MONTekmira receives $1.5M milestone payment from Monsanto
Tekmira Pharmaceuticals (TKMR) announced that it has received a $1.5M milestone payment from Monsanto (MON) following completion of specified program developments. The development milestone is part of the research program under the option agreement Tekmira signed with the agriculture company, which was announced on January 13. The option agreement relates to Tekmira's proprietary delivery technology and intellectual property for use in agricultural applications. The potential value of the transaction could reach up to $86.2M, following the successful completion of all program milestones.
News For TKMR;MON From The Last 14 Days
Check below for free stories on TKMR;MON the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
19:51 EDTTKMRFrance discusses Ebola drug trials with Guinea authorities, Bloomberg says
Subscribe for More Information
August 28, 2014
09:52 EDTTKMRTekmira rally sharply, levels to watch
Subscribe for More Information
06:46 EDTTKMRTekmira volatility at low end of range on wide price movement
Subscribe for More Information
August 27, 2014
18:38 EDTTKMROn The Fly: After Hours Movers
Subscribe for More Information
17:49 EDTTKMRGSK, Shire rumored to be interested in Tekmira, Daily Mail says
GlaxoSmithKline (GSK) and Shire (SHPG) are rumored to be interested in a bid for Tekmira (TKMR), reports Daily Mail. Tekmira could be a value to potential suitors, capitalized at approximately GBP 400M and the company could cost over GBP 1B in a takeover, Daily Mail adds. Reference Link
August 26, 2014
09:30 EDTMONGlobal Hunter Securities to hold meetings at farm show
Global Hunter Events at Farm Progress Show in Boone, Iowa on August 26-27.
09:25 EDTMONFarm Progress Companies to hold a show
Subscribe for More Information
August 22, 2014
08:15 EDTMONMonsanto can execute another reinvention, says Citigroup
Citigroup believes Monsanto is reinventing itself like it did when Roundup went off patent in the late 1990's by using the cash flow from the seeds business to get into new growth areas. Citi thinks management can execute the transition but admits the stock may be range-bound over the near-term. The firm keeps a Buy rating on Monsanto with a $146 price target.
August 20, 2014
14:11 EDTTKMRTekmira lipid nanoparticle targeting Marburg virus highlighted in journal
Subscribe for More Information
12:07 EDTMONMonsanto expects to at least double year ongoing EPS by end of FY19
Subscribe for More Information
12:03 EDTMONMonsanto says on track to deliver upper end of FY14 outlook
Subscribe for More Information
August 18, 2014
10:01 EDTTKMROn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:46 EDTTKMRTekmira initiated with an Outperform at Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use